Literature DB >> 3701253

Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway.

M S Krangel.   

Abstract

Human class I major histocompatibility antigens (HLA-A, -B and -C) are integral membrane protein heterodimers, which are anchored in the membrane via a stretch of hydrophobic amino acids near the carboxyl terminus of the heavy chain. It has previously been shown that a mutagenized cell line secretes a water soluble form of the HLA-A2 antigen, due to a pattern of RNA splicing that removes exon 5 (encoding the transmembrane hydrophobic amino acids) from mature, HLA-A2--encoding transcripts. The present study was undertaken to assess whether a similar process might be operative in nonmutagenized cells. It is shown that water soluble class I molecules (primarily HLA-A24) are secreted by the T leukemic cell line HPB-ALL, and that alternative splicing removes exon 5 from a fraction of HLA-A24--encoding transcripts. It is further shown that class I molecules are secreted, possibly in an allele-specific fashion, from a variety of tumor cells and normal cells. The possible relationship between these findings and previous reports of HLA-A and -B antigens in human serum is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3701253      PMCID: PMC2188102          DOI: 10.1084/jem.163.5.1173

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Biologic and chemical characterization of HLA antigens in human serum.

Authors:  J P Allison; M A Pellegrino; S Ferrone; G N Callahan; R A Reisfeld
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines.

Authors:  J Minowada; G Janossy; M F Greaves; T Tsubota; B I Srivastava; S Morikawa; E Tatsumi
Journal:  J Natl Cancer Inst       Date:  1978-06       Impact factor: 13.506

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Detergent-soluble HLA antigens contain a hydrophilic region at the COOH-terminus and a penultimate hydrophobic region.

Authors:  T A Springer; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

6.  Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2.

Authors:  P Parham; W F Bodmer
Journal:  Nature       Date:  1978-11-23       Impact factor: 49.962

7.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Soluble HLA antigens present in normal human serum.

Authors:  R J Billing; M Safani; P Peterson
Journal:  Tissue Antigens       Date:  1977-08

10.  Unusual RNA splicing generates a secreted form of HLA-A2 in a mutagenized B lymphoblastoid cell line.

Authors:  M S Krangel
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

View more
  57 in total

1.  Inhibition of Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocyte (CTL) activity by soluble HLA class I in vitro.

Authors:  B Gansuvd; M Hagihara; B Munkhbat; N Kanai; N Morita; N Munkhtuvshin; J Chargui; S Kato; T Hotta; K Tsuji
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

2.  Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment.

Authors:  F Puppo; F Torre; P Contini; M Ghio; S Brenci; R Brizzolara; N Sinelli; N Campo; F Indiveri; A Picciotto
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

Review 3.  Interplay between T helper type 1 and type 2 cytokines and soluble major histocompatibility complex molecules: a paradigm in pregnancy.

Authors:  Irene Athanassakis; S Vassiliadis
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

4.  Expression of alternatively spliced HLA class II transcripts in lymphoid and nonlymphoid tissues.

Authors:  C Seidl; J S Lee
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

5.  Transmembrane and cytoplasmic domain sequences demonstrate at least two expressed bovine MHC class I loci.

Authors:  S A Ellis; K A Braem; W I Morrison
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

6.  Mining the plasma immunopeptidome for cancer peptides as biomarkers and beyond.

Authors:  Heather D Hickman; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

7.  Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay.

Authors:  I Doxiadis; U Westhoff; H Grosse-Wilde
Journal:  Blut       Date:  1989-11

8.  Identification, characterization, and quantitation of soluble HLA antigens in the circulation and peritoneal dialysate of renal patients.

Authors:  F B Gelder; J C McDonald; M D Landreneau; R M McMillan; D F Aultman
Journal:  Ann Surg       Date:  1991-06       Impact factor: 12.969

9.  Transfection into mouse L cells of genes encoding two serologically and functionally distinct bovine class I MHC molecules from a MHC-homozygous animal: evidence for a second class I locus in cattle.

Authors:  P G Toye; N D MacHugh; A M Bensaid; S Alberti; A J Teale; W I Morrison
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

10.  Soluble HLA class I in the serum of transplant recipients.

Authors:  V K Rhynes; J C McDonald; F B Gelder; D F Aultman; J M Hayes; R W McMillan; M C Mancini
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.